Clinical trial
Ifosfamide and Doxorubicin, Radiation Therapy, and/or Surgery in Treating Young…
NCT00334854 · European Paediatric Soft Tissue Sarcoma Study Group, Other · Unknown status
Key facts
| NCT number | NCT00334854 |
|---|---|
| Title | Ifosfamide and Doxorubicin, Radiation Therapy, and/or Surgery in Treating Young Patients With Localized Soft Tissue Sarcoma |
| Official title | Localized Non-Rhabdomyosarcoma Soft Tissue Sarcomas |
| Lead sponsor | European Paediatric Soft Tissue Sarcoma Study Group, Other |
| Collaborators | Italian Association for Pediatric Hematology Oncology Cooperative Weichteilsarkom Studie Children's Cancer and Leukaemia Group Dutch Childhood Oncology Group |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Childhood Malignant Fibrous Histiocytoma of Bone, Sarcoma |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | doxorubicin hydrochloride, ifosfamide, adjuvant therapy, conventional surgery, neoadjuvant therapy, radiation therapy |
| Enrollment | 250 |
| Start date | Mar 1, 2006 |
| Primary completion | May 1, 2010 |
| First posted | Jun 8, 2006 |
| Last update posted | Aug 12, 2013 |
| Countries | Austria, Belgium, Denmark, France, Ireland, Spain, Sweden, Switzerland, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: